Company intelligence / Profile preview

Hebei Inatural Biotech

Shijiazhuang, Hebei, China

Ownership: Private
Development stage: Other

Overview

Company has developed multiple proprietary probiotic strains, with over 80 patents. Some strains are used in clinical research and commercial food or supplement products. Clinical results are primarily published in animal model studies showing efficacy in gut health and metabolic disease models

Therapeutic areas: Metabolic DisordersGastroenterology
Modalities: Live biotherapeutic product therapy (probiotic strains including Bifidobacterium longum, Lactobacillus rhamnosus, etc.)Microbial therapyPlant-based fermentation agents
Industry: Biotech

Drug pipeline

11 assets

Lactobacillus paracei YMC1069

Preclinical

10 more assets in the full pipeline.

Request access →

Partnerships

Partnerships with academic institutions (e.g., Sichuan University for probiotic research in published studies)

Beyond the preview

Go deeper on Hebei Inatural Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hebei Inatural Biotech.

Explore the full profile